drugset / Trial / NCT00392041

Eszopiclone in the Treatment of Insomnia and Fibromyalgia

NCT00392041

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose is to assess the efficacy of eszopiclone for the treatment of insomnia and other symptoms of fibromyalgia. It is hypothesized that participants receiving eszopiclone will report greater improvement in total sleep time, sleep quality, pain, fatigue, physical functioning, and emotional distress than will those receiving placebo.

Timeline

Start
2006-08
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg

Indications